The Path from Biomarker Discovery to Regulatory Qualification - Federico Goodsaid - Books - Elsevier Science Publishing Co Inc - 9780123914965 - August 7, 2013
In case cover and title do not match, the title is correct

The Path from Biomarker Discovery to Regulatory Qualification

Federico Goodsaid

Price
₺ 3,217
excl. VAT

Ordered from remote warehouse

Expected delivery Oct 8 - 21
Add to your iMusic wish list

The Path from Biomarker Discovery to Regulatory Qualification

Focuses on biomarker qualification, its history and regulatory settings in both the US and abroad. This book provides a look at the next step to developing biomarkers for clinical use and covers overall concepts, challenges, strategies and solutions based on the experiences of regulatory authorities and scientists.


206 pages, Illustrated

Media Books     Paperback Book   (Book with soft cover and glued back)
Released August 7, 2013
ISBN13 9780123914965
Publishers Elsevier Science Publishing Co Inc
Pages 206
Dimensions 192 × 235 × 10 mm   ·   408 g
Language English  
Editor Goodsaid, Federico (PhD, Vice President, Strategic Regulatory Intelligence, Vertex Pharmaceuticals, Cambridge, MA)
Editor Mattes, William B. (PhD, DABT, Senior Director of COPD Biomarkers Qualification Consortium, COPD Foundation and Founder and Principal, PharmPoint Consulting)